ACADIA Pharmaceuticals Inc (ACAD)
16.70
-0.40
(-2.34%)
USD |
NASDAQ |
Apr 30, 16:00
16.70
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Free Cash Flow: -23.35M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.35M |
| September 30, 2023 | -132.59M |
| June 30, 2023 | -74.31M |
| March 31, 2023 | -55.64M |
| December 31, 2022 | -114.04M |
| September 30, 2022 | -113.30M |
| June 30, 2022 | -129.64M |
| March 31, 2022 | -141.89M |
| December 31, 2021 | -126.78M |
| September 30, 2021 | -133.15M |
| June 30, 2021 | -140.60M |
| March 31, 2021 | -155.04M |
| December 31, 2020 | -143.75M |
| September 30, 2020 | -144.18M |
| June 30, 2020 | -138.60M |
| March 31, 2020 | -137.20M |
| December 31, 2019 | -152.26M |
| September 30, 2019 | -161.95M |
| June 30, 2019 | -186.31M |
| March 31, 2019 | -188.89M |
| December 31, 2018 | -169.57M |
| September 30, 2018 | -159.87M |
| June 30, 2018 | -175.03M |
| March 31, 2018 | -193.21M |
| December 31, 2017 | -218.57M |
| Date | Value |
|---|---|
| September 30, 2017 | -250.10M |
| June 30, 2017 | -241.38M |
| March 31, 2017 | -247.54M |
| December 31, 2016 | -217.91M |
| September 30, 2016 | -191.49M |
| June 30, 2016 | -173.80M |
| March 31, 2016 | -139.02M |
| December 31, 2015 | -123.94M |
| September 30, 2015 | -106.82M |
| June 30, 2015 | -92.34M |
| March 31, 2015 | -78.76M |
| December 31, 2014 | -66.61M |
| September 30, 2014 | -59.11M |
| June 30, 2014 | -51.44M |
| March 31, 2014 | -39.99M |
| December 31, 2013 | -32.39M |
| September 30, 2013 | -28.29M |
| June 30, 2013 | -23.71M |
| March 31, 2013 | -22.99M |
| December 31, 2012 | -21.63M |
| September 30, 2012 | -20.67M |
| June 30, 2012 | -19.54M |
| March 31, 2012 | -20.02M |
| December 31, 2011 | -19.90M |
| September 30, 2011 | -9.958M |
Free Cash Flow Range, Past 5 Years
-186.31M
Minimum
Jun 2019
-23.35M
Maximum
Dec 2023
-126.56M
Average
-137.20M
Median
Mar 2020
Free Cash Flow Benchmarks
| Amylyx Pharmaceuticals Inc | 10.68M |
| Regulus Therapeutics Inc | -27.38M |
| Tonix Pharmaceuticals Holding Corp | -109.90M |
| Minerva Neurosciences Inc | -14.78M |
| Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 85.39M |
| Cash from Investing (Quarterly) | -0.347M |
| Cash from Financing (Quarterly) | 5.434M |
| Free Cash Flow Per Share (Quarterly) | 0.5181 |
| Free Cash Flow to Equity (Quarterly) | 85.39M |
| Free Cash Flow to Firm (Quarterly) | 85.39M |
| Free Cash Flow Yield | -0.85% |